Peritoneal carcinomatosis: Intra-operative and post-operative assessment of patients undergoing cytoreduction and HIPEC

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1052-1059

  Spiliotis, John ^a   Vaxevanidou, Arhodoula ^b   Datsis, Anastasios ^c   Rogdakis, Athanasios ^c   Kekelos, Spyridon ^c  

^a METAXA CANCER HOSPITAL   (Greece)

^b G Genimatas Hospital   (Greece)

^c Saint Panteleimon Hospital   (Greece)

Author keywords

HIPEC; Peritoneal corcinomatosis

Indexed keywords

CISPLATIN; CREATININE; DOXORUBICIN; HEMOGLOBIN; IRINOTECAN; MITOMYCIN; OXALIPLATIN; PHOSPHORUS; SERUM ALBUMIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL EVALUATION; COLORECTAL CANCER; CREATININE BLOOD LEVEL; CYTOREDUCTIVE SURGERY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTHERMIC INTROPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; INTESTINE FISTULA; INTRAOPERATIVE PERIOD; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYOCARDIAL DISEASE; NEUTROPENIA; ONCOLOGICAL PARAMETERS; OVARY CANCER; PANCREATITIS; PERITONEUM PSEUDOMYXOMA; PHOSPHATE BLOOD LEVEL; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; SARCOMA; SEPSIS; SIDE EFFECT; STOMACH CANCER; SURGICAL INFECTION; THROMBOCYTOPENIA;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS;

EID: 79251591327     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD: Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol. 2001 Feb; 27(1):65-73.
2. Teo M, Foo KF, Koo WH, Wong LT, Soo KC: Lessons learned from initial experience with peritoneotomy and intraperitoneal chemotherapy infusion. World J Surg. 2006 Dec; 30(12):2132-5. (Pubitemid 44885166)
3. Sugarbaker PH: Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol. 2007 Feb 1; 95(2):93-6.
4. Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Endou Y, Miura M: The natural history of free cancer cells in the peritoneal cavity- Recent Results Cancer Res. 2007; 169:11-23.
5. Elias D, Pietrantonio D Di, Boulet T, Honore C, Bonnet S, Goere D, Kohneh-Shahri N, Raynard B: "Natural history" of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2009; 35(4):438-438.
6. Sugarbaker PH: Peritonectomy procedures. Cancer Ther Rest 2007; 134:247-264.
7. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed). Peritoneal carcinomatosis principles of management. Kluwer Academic Publishers Boston 1996; 359-374.
8. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6:727-731.
9. Elias D, Pocard M, Goere D: HTPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat Res. 2007; 134:303-18.
10. Spiliotis J, Tentes AA, Vaxevanidou A, Korakianitis OS, Rogdakis A, Mirelis CG, Datsis AC, Kekelos S: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece. JBUON. 2008 Apr-Jun; 13(2):205-10.
11. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D: Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006 May; 13(5):635-44. Epub 2006 Mar 10.
12. Elias D, Raynard B, Boige V, Laplanche A, Estphan G, Malka D, Pocard M: Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol. 2005 Jun 15; 90(4):220-5.
13. Yan TD, Sim J, Morris DL: Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2007 Jun; 14(6):1807-17. Epub 2007 Mar 8.
14. Schmidt C, Creutzenberg M, Piso P, Hobbhahn J, Bucher M: Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 2008 Apr; 63(4):389-95. (Pubitemid 351365036)
15. Kanakoudis F, Petrou A, Michaloudis D, Chortaria G, Konstantinidou A: Anaesthesia for intraperitoneal perfusion of hyperthermic chemotherapy. Haemodynamic changes, oxygen consumption and delivery. Anaesthesia. 1996Nov;51(11):1033-6.
16. Rankovic VI, Masirevic VP, Pavlov MJ, Ceranic MS, Milenkovic MG, Simic AP, Kecmanovic DM: Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy. Hepatogastroenterology. 2007 Mar; 54(74):364-6.
17. Dahlke MH, Schlitt HJ, Piso P: Continuous peritoneal perfusion: techniques, methods and applications. Cancer Treat Res. 2007; 134:265-73.
18. Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH: Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique". Ann Surg Oncol. 2000 May; 7(4):296-300.
19. Royal R, Pingpank J: Diagnosis and management of peritoneal carcinomatosis. Arising from adenocarcinoma of the colon and Rectum. Seminars in Oncol. 2008, 35(2)183-191.
20. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg. 2000 Jun; 66(6):561-8.